胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)是预后极差的恶性肿瘤,miRNA在PDAC中的研究为其诊断、治疗、评价预后及了解其恶性生物学行为带来新方向和新思路.
基于170个网页-相关网页
·2,447,543篇论文数据，部分数据来源于NoteExpress
背景：手术切除已被证明是影响胰腺导管腺癌(PDAC)患者生存一个主要因素。
Background: Curative resection has been shown to be one of the key factors influencing survival of pancreatic ductal adenocarcinoma (PDAC) patients.
本文报告22例胰腺癌周围胰腺的组织学变化。癌周胰腺可见弥漫性慢性炎症及导管内高压征。
In all of the 22 cases of patients with pancreatic carcinoma, diffuse chronic pancreatitis, intraductal hypertension, and epithelial hyperplasia are found in the surrounding pancreatic tissue.
应用推荐